Rani Therapeutics Holdings (RANI) Construction in Progress (2020 - 2021)
Rani Therapeutics Holdings (RANI) posted quarterly Construction in Progress of $3.5 million for Q4 2021, little changed year-over-year from $3.5 million in Q4 2020, and little changed quarter-over-quarter from $3.5 million in Q4 2020.
Rani Therapeutics Holdings (RANI) Construction in Progress (2020 - 2021) Analysis & Trends
Rani Therapeutics Holdings' Construction in Progress history runs 2 years deep, the most recent figure standing at $3.5 million for Q4 2021.
- In Q4 2021, Construction in Progress changed 0.0% year-over-year to $3.5 million; the TTM figure through Dec 2021 stood at $3.5 million (changed 0.0% YoY), while the FY2021 annual figure was $3.5 million, changed 0.0% from the prior year.
- Construction in Progress for Q4 2021 stood at $3.5 million, roughly flat from $3.5 million in the prior quarter.
- The five-year high for Construction in Progress was $3.5 million in Q4 2020, with the low at $3.5 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 152.67 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Rani Therapeutics Holdings | 160.33 Mn | 160.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 3.50 Mn |
| Dec 31, 2020 | 3.50 Mn |